-
公开(公告)号:HUT77377A
公开(公告)日:1998-04-28
申请号:HU9702260
申请日:1995-09-27
Applicant: GLAXO WELLCOME INC
Inventor: JOHNSON KEITH ARTHUR , LI-BOVET LI
Abstract: PCT No. PCT/IB95/00866 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Sep. 27, 1995 PCT Pub. No. WO96/09816 PCT Pub. Date Apr. 4, 1996 (I) A pharmaceutical aerosol formulation which comprises particulate medicament, a fluorocarbon of hydrogen-containing chlorofluorocarbon propellant and a surfactant of general formula (I), wherein n is an integer of 1 to 18; m is an integer of 0 to 17; and R1, R2 and R3 are each independently a hydrogen atom or a C1-4alkyl group.
-
公开(公告)号:SK139197A3
公开(公告)日:1998-04-08
申请号:SK139197
申请日:1996-04-11
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
IPC: B65D83/38 , A61K9/00 , A61K9/12 , A61K9/72 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/00 , A61P11/00 , B05D5/08 , B65D83/14
Abstract: A metered dose inhaler having part or all of its internal surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising beclomethasone dipropionate or a physiologically acceptable solvate thereof, and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.
-
公开(公告)号:TR9701167T1
公开(公告)日:1998-03-21
申请号:TR9701167
申请日:1996-04-10
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST LAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL THOMAS
IPC: A61K9/00 , A61K9/12 , A61K9/72 , A61K31/135 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/00 , A61P11/08 , B05D5/08 , B05D7/22 , B05D7/24 , B65D83/14
CPC classification number: A61K9/008 , A61K9/124 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/009 , A61M2205/0222 , B65D83/54 , A61K31/135 , A61K2300/00
-
公开(公告)号:CZ9703259A3
公开(公告)日:1998-03-18
申请号:CZ325997
申请日:1996-04-10
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
IPC: A61K9/00 , A61K9/12 , A61K9/72 , A61K31/135 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/00 , A61P11/08 , B05D5/08 , B05D7/22 , B05D7/24 , B65D83/14
CPC classification number: A61K9/008 , A61K9/124 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/009 , A61M2205/0222 , B65D83/54 , A61K31/135 , A61K2300/00
-
公开(公告)号:NO974737A
公开(公告)日:1997-12-11
申请号:NO974737
申请日:1997-10-13
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
IPC: A61K9/00 , A61K9/12 , A61K9/72 , A61K31/135 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/00 , A61P11/08 , B05D5/08 , B05D7/22 , B05D7/24 , B65D83/14
CPC classification number: A61K9/008 , A61K9/124 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/009 , A61M2205/0222 , B65D83/54 , A61K31/135 , A61K2300/00
-
公开(公告)号:NO974735L
公开(公告)日:1997-12-11
申请号:NO974735
申请日:1997-10-13
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
IPC: A61K9/12 , A61M15/00 , A61K31/56 , A61K31/569 , A61M15/08 , A61M16/00 , A61P11/00 , B05D5/00 , B05D5/08 , B65D83/14
Abstract: A metered dose inhaler having part or all of its internal surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising fluticasone propionate, or a physiologically acceptable solvate thereof, and a fluorocarbon propellant optionally in combination with one or more other pharmacologically active agents or one or more excipients.
-
公开(公告)号:NO974738D0
公开(公告)日:1997-10-13
申请号:NO974738
申请日:1997-10-13
Applicant: GLAXO WELLCOME INC
Inventor: ASHURST IAN C , HERMAN CRAIG S , LI-BOVET LI , RIEBE MICHAEL T
IPC: B65D83/38 , A61K9/00 , A61K9/12 , A61K9/72 , A61K31/137 , A61K31/57 , A61K31/573 , A61M15/00 , A61P11/00 , B05D5/08 , B65D83/14 , A61M
Abstract: A metered dose inhaler having part or all of its internal surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formulation comprising beclomethasone dipropionate or a physiologically acceptable solvate thereof, and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.
-
公开(公告)号:CZ93697A3
公开(公告)日:1997-08-13
申请号:CZ93697
申请日:1995-09-27
Applicant: GLAXO WELLCOME INC
Inventor: LI-BOVET LI , JOHNSON KEITH ARTHUR
Abstract: PCT No. PCT/IB95/00866 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Sep. 27, 1995 PCT Pub. No. WO96/09816 PCT Pub. Date Apr. 4, 1996 (I) A pharmaceutical aerosol formulation which comprises particulate medicament, a fluorocarbon of hydrogen-containing chlorofluorocarbon propellant and a surfactant of general formula (I), wherein n is an integer of 1 to 18; m is an integer of 0 to 17; and R1, R2 and R3 are each independently a hydrogen atom or a C1-4alkyl group.
-
公开(公告)号:FI971279A0
公开(公告)日:1997-03-26
申请号:FI971279
申请日:1997-03-26
Applicant: GLAXO WELLCOME INC
Inventor: LI-BOVET LI , JOHNSON KEITH ARTHUR
Abstract: PCT No. PCT/IB95/00866 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Sep. 27, 1995 PCT Pub. No. WO96/09816 PCT Pub. Date Apr. 4, 1996 (I) A pharmaceutical aerosol formulation which comprises particulate medicament, a fluorocarbon of hydrogen-containing chlorofluorocarbon propellant and a surfactant of general formula (I), wherein n is an integer of 1 to 18; m is an integer of 0 to 17; and R1, R2 and R3 are each independently a hydrogen atom or a C1-4alkyl group.
-
公开(公告)号:CA2200986A1
公开(公告)日:1996-04-04
申请号:CA2200986
申请日:1995-09-27
Applicant: GLAXO WELLCOME INC
Inventor: LI-BOVET LI , JOHNSON KEITH ARTHUR
Abstract: A pharmaceutical aerosol formulation which comprises particulate medicament, a fluorocarbon of hydrogen-containing chlorofluorocarbon propellant and a surfactant of general formula (I), wherein n is an integer of 1 to 18; m is an integer of 0 to 17; and R1, R2 and R3 are each independently a hydrogen atom or a C1-4alkyl group.
-
-
-
-
-
-
-
-
-